Hypomyelination and congenital cataract
Alternate names[edit]
Leukodystrophy, hypomyelinating, 5; HLD5; Hypomyelination - congenital cataract
Definition[edit]
Hypomyelination and congenital cataract is a very rare disease characterized by cloudy coverings of the eye that are present at birth (congenital cataracts) and neurologic impairment that becomes apparent after the first year of life.
Cause[edit]
- Hypomyelination and congenital cataract is caused by a change (mutation ) in the FAM126A gene.
- The FAM126A gene provides instructions for making a protein called hyccin, the function of which is not completely understood.
- Hyccin is involved in the formation of myelin throughout the nervous system.
Gene mutations[edit]
- Most FAM126A gene mutations that cause hypomyelination and congenital cataract prevent the production of hyccin.
- People who cannot produce any hyccin have problems forming myelin, leading to the signs and symptoms of this condition.
Inheritance[edit]

It is inherited in an autosomal recessive manner.
Signs and symptoms[edit]
- This condition is characterized by cloudy coverings of the eye that are present at birth (congenital cataracts) and neurologic impairment that becomes apparent after the first year of life.
- The neurologic impairment is progressive and presents as ataxia and spasticity.
- Affected individuals may lose the ability to walk.
- Signs and symptoms may vary but can include loss of sensation in the hands and feet (peripheral neuropathy), curvature of the spine (scoliosis), difficulty speaking (dysarthria), seizures, and moderate intellectual disability.
Clinical presentation[edit]
For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.
80%-99% of people have these symptoms
- Abnormal cerebellum morphology(Abnormality of the cerebellum)
- Abnormal pyramidal sign
- Cerebral hypomyelination
- Developmental cataract(Clouding of the lens of the eye at birth)
- Global developmental delay
- Intellectual disability, moderate(IQ between 34 and 49)
Diagnosis[edit]
- Diagnosis of hypomyelination and congenital cataract is based on clinical findings of muscle weakness and cataracts, and a brain MRI that indicates a loss of the myelin surrounding the neurons.
- The diagnosis can be confirmed by genetic testing of the FAM126A gene.
Treatment[edit]
- Treatment is focused on relieving symptoms of the condition and may include physical therapy, special education, and medication to treat seizures.
- Cataract extraction usually in the first months of life.
- Therapy support for developmental delays
- Special education
- Physical medicine and rehabilitation for spasticity and ataxia.
- Treatment for scoliosis and contractures per orthopedist
- Feeding therapy and or gastrostomy tube as needed.[1][1].
References[edit]
- ↑ Wolf NI, Biancheri R, Zara F, et al. Hypomyelination and Congenital Cataract. 2008 Oct 14 [Updated 2021 Jan 14]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK2587/
NIH genetic and rare disease info[edit]
Hypomyelination and congenital cataract is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Hypomyelination and congenital cataract
|
|
This article is a stub You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia. |
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian